Evidence map›Paper›PMID 37746652›Full record

ArticleWorld journal of gastrointestinal oncology2023

Hemoglobin, albumin, lymphocyte, and platelet score as a predictor of prognosis in metastatic gastric cancer.

Yakup Duzkopru, Abdulkadir Kocanoglu, Ozlem Dogan, Hayriye Sahinli, Ebru Cilbir, Mustafa Altinbas

Open access · diamondAbstract read
In one paragraph

Article in World journal of gastrointestinal oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. The HALP score as a prognostic factor in metastatic biliary cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yakup DuzkopruDepartment of Medical Oncology, Ankara Etlik City Hospital, Ankara 06170, Turkey.
Abdulkadir KocanogluDepartment of Medical Oncology, Ankara Etlik City Hospital, Ankara 06170, Turkey.
Ozlem DoganDepartment of Medical Oncology, Ankara Etlik City Hospital, Ankara 06170, Turkey.
Hayriye SahinliDepartment of Medical Oncology, Ankara Etlik City Hospital, Ankara 06170, Turkey.
Ebru CilbirDepartment of Medical Oncology, Ankara Etlik City Hospital, Ankara 06170, Turkey.
Mustafa AltinbasDepartment of Medical Oncology, Ankara Etlik City Hospital, Ankara 06170, Turkey.
Memorial Ankara Hospital · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe hemoglobin, albumin, lymphocyte, and platelet (HALP) score, derived from a composite evaluation of markers reflecting the tumor-inflammation relationship and nutritional status, has been substantiated as a noteworthy prognostic determinant for diverse malignancies.

aimTo investigate how the HALP score relates to prognosis in patients with metastatic gastric cancer.

methodsThe cutoff values for the HALP score, neutrophil/lymphocyte ratio, and platelet/lymphocyte ratio were determined using receiver operating characteristic analysis. Low HALP scores were defined as those less than 24.79 and high HALP scores as those greater than 24.79.

resultsThe study cohort comprised 147 patients and 110 of them (74.8%) were male. The patients' median age was 63 (22-89) years. The median overall survival was significantly superior in the patients with high HALP scores than in those with low HALP scores (10.4 mo

conclusionThe HALP score was found to be a prognostic factor in patients with metastatic gastric cancer.

Indexed as

BiomarkerGastric cancerHemoglobin, albumin, lymphocyte, and platelet scoreNutritional indexPrognosisSurvival

Identifiers

PMID37746652
PMCPMC10514725
OpenAlexW4386649911

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.